Advertisement
CYTK vs DICE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and DICE is a Hold.
CYTK's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for CYTK turned positive on October 13, 2026. Looking at past instances where CYTK's MACD turned positive, the stock continued to rise in 45 of 56 cases over the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CYTK's RSI Indicator exited the oversold zone, 19 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 68 cases where CYTK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on CYTK as a result. In 75 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
Following a +2.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYTK advanced for three days, in 211 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
CYTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 50-day moving average for CYTK moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for CYTK entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. CYTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-44.515) is normal, around the industry mean (2.904). P/E Ratio (-7.694) is within average values for comparable stocks, (-0.738). CYTK's Projected Growth (PEG Ratio) (82.230) is slightly higher than the industry average of (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (128.205) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CYTK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 78 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 62 | |
P/E GROWTH RATING 1..100 | 24 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CYTK | |
|---|---|
| RSI ODDS (%) | 2 days ago 79% |
| Stochastic ODDS (%) | 2 days ago 74% |
| Momentum ODDS (%) | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 71% |
| TrendMonth ODDS (%) | 2 days ago 74% |
| Advances ODDS (%) | 2 days ago 72% |
| Declines ODDS (%) | 4 days ago 78% |
| BollingerBands ODDS (%) | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 83% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CYTK’s FA Score shows that 1 FA rating(s) are green while .
- CYTK’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CYTK’s TA Score shows that 6 TA indicator(s) are bullish.
- CYTK’s TA Score: 6 bullish, 3 bearish.
Price Growth
CYTK (@Biotechnology) experienced а +3.79% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -8.72%. For the same industry, the average monthly price growth was -14.23%, and the average quarterly price growth was -21.13%.
Reported Earning Dates
CYTK is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Biotechnology (-8.72% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
DICE and
Correlation & Price change
A.I.dvisor tells us that DICE and IPSC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DICE and IPSC's prices will move in lockstep.
| Ticker / NAME | Correlation To DICE | 1D Price Change % | ||
|---|---|---|---|---|
| DICE | 100% | +1.62% | ||
| IPSC - DICE | 32% Poorly correlated | +9.87% | ||
| CYTK - DICE | 32% Poorly correlated | +2.07% | ||
| CLDX - DICE | 31% Poorly correlated | +0.74% | ||
| VKTX - DICE | 30% Poorly correlated | +7.21% | ||
| ORMP - DICE | 30% Poorly correlated | +3.25% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KWT | 36.50 | 1.78 | +5.11% |
| iShares MSCI Kuwait ETF (KWT) | |||
| XLY | 122.33 | 5.00 | +4.26% |
| State Street Consumer Discretionary Select Sector SPDR ETF (XLY) | |||
| DTRE | 42.87 | 1.28 | +3.07% |
| First Trust Alerian Disruptive Technology Real Estate ETF (DTRE) | |||
| LST | 47.87 | 0.37 | +0.78% |
| Leuthold Select Industries ETF | |||
| UFOX | 74.59 | -1.35 | -1.78% |
| Defiance Space and Connective Tech ETF (UFOX) | |||